HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Smith+Nephew REGENETEN Bioinductive Implant New Study

Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces study results showing patients treated with just its REGENETEN Bioinductive Implant for partial-thickness rotator cuff...

Late-Breaking Trial Data at TVT Demonstrate Sustained Safety and Performance of WATCHMAN FLX™ Left Atrial Appendage Closure Device

Key findings include: The trial met its secondary effectiveness endpoint – defined as the occurrence of ischemic stroke or systemic embolism over 24 months – with a rate of 3.4% compared to the performance goal of 8.7%. No patients experienced a device embolization or pericardial effusion requiring cardiac surgery through 24 months.

Retia Medical Reports Multi-Beat Analysis Algorithm New Study Further Confirms Superior Accuracy in Comparison to a Competing Option

The study compared the accuracy of two cardiac output monitors, the Retia Argos and the Edwards Lifesciences FloTrac across 58 patients undergoing off-pump coronary artery bypass surgery, yielding 572 sets of cardiac output measurements from each device.

Aerin Medical Announces Results of Randomized Controlled Trial Supporting VivAer® for Treatment of Nasal Airway Obstruction With Nasal Valve Collapse

Treatment with VivAer, a non-invasive, temperature-controlled, radiofrequency (RF) device, resulted in significant symptom relief, superior to sham control.

MD Orthopaedics Publishes Clubfoot Chronicles, One Parent’s Heartfelt and Personal Account of Life With a Clubfoot Child

Clubfoot is one of the most common musculoskeletal birth defects, affecting one out of every 100 babies born worldwide.

IntraOp Medical Announces First Patients Enrolled in FLASH Clinical Trial

Impulse Trial is the first to evaluate the curative potential of the FLASH Effect

Philips Enrolls 1st Patient in the WE-TRUST Global Multicenter Stroke Study

The first patient enrolled in global multi-center randomized controlled trial with 564 patients at 15 sites comparing the impact of the Direct to Angio Suite workflow (diagnosis and treatment in the angio suite) to the conventional workflow (diagnosis in the CT or MRI suite followed by treatment in the angio suite) on stroke patient outcomes. WE-TRUST trial to provide most comprehensive assessment to date with the help of an advanced brain scan technology in the angio suite for more effective and efficient stroke patient outcomes.

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

DEFINE AFib Study will leverage data from Medtronic insertable cardiac monitors and Medtronic Discovery App™ with the goal of informing atrial fibrillation (AF) management strategies